PMC:7543522 / 3058-3769 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T9	85-86	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a
T10	201-208	http://purl.obolibrary.org/obo/UBERON_0000473	denotes	testing
T11	273-276	http://purl.obolibrary.org/obo/CLO_0051582	denotes	has
T12	627-631	http://purl.obolibrary.org/obo/CLO_0008416	denotes	peer
T13	627-631	http://purl.obolibrary.org/obo/CLO_0050081	denotes	peer

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
22	432-440	Species	denotes	patients	Tax:9606
23	379-397	Chemical	denotes	hydroxychloroquine	MESH:D006886
24	414-427	Chemical	denotes	dexamethasone	MESH:D003907
25	446-454	Disease	denotes	COVID-19	MESH:C000657245

Id	Subject	Object	Predicate	Lexical cue
T11	0-711	Sentence	denotes	Despite the pressures that typically surround pandemics to implement treatments with a promising rationale directly including research invitations, the research community should assert the benefits of testing treatment hypotheses with methodological rigour.8 This approach has arguably led to reliable improvements in treatment, for example, demonstrating the ineffectiveness of hydroxychloroquine and benefits of dexamethasone for patients with COVID-19.9,10 While the investigators have used established methods such as randomised controlled trials, they have chosen to expedite publication of the results before traditional peer review, using press releases and preprint archives such as bioRxiv and medRxiv.